several 3D structures have been released, in 2 main conformations, in which the drug-binding region is accessible to the cytosol or to the extracellular space. Such conformations suggest thatABC ... crystallization of 2…
ofthe epitopes with MHC complex because the molecular modelling tools can provide information about binding energy, unbinding process, orbital energies and electrostatic interaction amongothers. In addition, the use of…
reactions are catalyzed and to derive QSAR models that help rationalize the determinants of binding affinity for inhibitors. Here we report results from computational, structural and biochemical studies that help…
ubiquitin ligase Siah, the antiapoptotic protein Bfl-1, and the EphA4 ligand binding domain. For the first two targets, structure-based design of peptide mimics ultimately led to potent
protein, phosphoprotein, matrix protein, polymerase protein, hemagglutinin-neuraminidase protein, and fusion protein. After the binding of virus to the host cell byhemagglutinin-neuraminidase protein, the fusion protein…
phage particles. This is an extremely powerful tool for selecting peptides with specific binding properties from vast numbers of variants. Considering tumors, is a promise technology in selecting targets with
molecule libraries. The screening of the libraries was performed using a homogenous (immobilization-free) binding assay relying on a unique principle of trapping the binding complexes-small molecule and target…
synthesized 7-oxo-pyrazolo[1, 5-a]pyrimidine-6-carboxamides were tested in competition binding assays toward both rat CB1 and CB2 receptors expressed in native tissues (rat brain
approach to drug metabolizing enzymes is a challenging process because they usually have flexible binding sites. We developed in silico structure-based protocol to gain mechanistic insights from probing small…
Finally, σ receptors were recognized as specific, non-opioid, non-PCP, but haloperidol-sensitive binding sites consisting of σ1 and σ2 subtypes. The two σ receptor subtypes can be differentiated ... molecular weight…
optimize the product?s pharmacodynamic factors. These factors include, but are not limited to, binding affinity, druglikeness, cLogP, LogS, molecular weight, and an overall risk for toxicity. The optimization process
heterocyclic, small molecule proteasome inhibitors regulate proteasome activity via a non-competitive mechanism, by binding in a site not previously targeted by any drugs. Considering that these agents interact with
peptide hormone secreted by skeletal muscle in mice andhumans. The hormone is thought to bind to so far unidentified surface receptor on white fat cellsand induces ?browning? effects that improve
discovery of small molecules targeting RXRα have been primarily focused on the molecules that bind to its classical ligand-binding pocket (LBP). Using structure-based approach and in collaboration with…
thus designed small molecules that efficiently target the molecular switch. These quadruplex-binding ligands will open up a new approach in cancer therapy (a). In the present work we tested
without interference, interact with their particular receptor/acceptor target and retain their individual binding affinities and efficacies at each target. Peptides are ideally suited for this purpose. This approach with
applied a modified self-organizing map algorithm for in silico recognition of molecular fragments binding both targets. The predicted properties were confirmed by complementary screening techniques: STD-NMR and enzyme
Screening a nuclear receptor compound subset in a RORc biochemical binding assay revealed a benzylic tertiary sulfonamide hit. Using structure-based drug design principles, we created compounds with improved RORc
replication in the infected cell. Our aim was to select and characterize aptamers that bind to the 5?-UTR using the matrix-free SELEX method and in silico analyses. Products
generating lead compounds. FBDD identifies low-molecular-weight ligands (less than 300 Da) that bind to biologically important macromolecular targets. The application of sensitive biophysical techniques to capture these…
different dimerization processes, resulting in either a homodimer or heterodimer, depending on the ligand binding, e.g. epidermal growth factor (EGF). The dimers formed pave way for protein phosphorylation, warranting
potential new potent PAP inhibitors. Docking studies have shown that the derivatives have high binding affinity due to the phosphonate moiety binding to the binuclear metal centre, which ... interactions with the…
structurally diverse compounds to explore prime structural features responsible for selective binding to AChE, and vis-à-vis inhibiting enzyme activity. Both the studies showed the importance of aromatic ring…
various malignancies. The hnRNPK protein has three KH domains, which are responsible for its binding with DNA and RNA. 15 hydrazide-hydrazonederivatives synthesized in our laboratory had their ability ... hnRNPK protein…
Division of Microbiology and Infectious Diseases, NIAID, National Institutes of Health, Bethesda (USA). The binding mode of compounds has been established by docking studies on receptor InhA (PDB id: 2H7M
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.